MFIM
GILD icon

Mesirow Financial Investment Management’s Gilead Sciences GILD Stock Holding History

Mesirow Financial Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$862K Buy
6,825
+55
+0.8% +$7.25K 0.01% 290
2026
Q1 		$944K Buy
6,770
+420
+7% +$58.8K 0.02% 272
2025
Q4 		$779K Sell
6,350
-1,014
-14% -$123K 0.02% 270
2025
Q3 		$817K Buy
7,364
+2
+0% +$227 0.01% 290
2025
Q2 		$816K Sell
7,362
-72
-1% -$7.66K 0.02% 283
2025
Q1 		$833K Buy
7,434
+442
+6% +$45.6K 0.02% 278
2024
Q4 		$646K Buy
6,992
+101
+1% +$9.09K 0.01% 315
2024
Q3 		$578K Sell
6,891
-92
-1% -$7.02K 0.01% 341
2024
Q2 		$479K Sell
6,983
-70
-1% -$4.67K 0.01% 333
2024
Q1 		$517K Sell
7,053
-1,340
-16% -$103K 0.01% 336
2023
Q4 		$680K Buy
+8,393
New +$653K 0.02% 266

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mesirow Financial Investment Management's GILD Position: Q2 2026 in Review

Mesirow Financial Investment Management increased its Gilead Sciences (GILD) stake by 0.81% in Q2 2026, buying an estimated $7.25K and bringing the position to 6,825 shares worth $862K. The position accounts for 0.01% of the portfolio, ranked #290.

Mesirow Financial Investment Management first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $944K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Mesirow Financial Investment Management held 6,825 shares of Gilead Sciences worth $862K as of Q2 2026.
  • Mesirow Financial Investment Management bought 55 Gilead Sciences shares in Q2 2026, an estimated $7.25K.
  • Gilead Sciences made up 0.01% of Mesirow Financial Investment Management's portfolio in Q2 2026, its #290 holding.
  • Mesirow Financial Investment Management first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • Mesirow Financial Investment Management's Gilead Sciences position peaked at $944K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Mesirow Financial Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.